Vesencumab (Anti-NRP1 / VEGF165R / CD304)
Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2682 |
| Sku # | A2682-1mg*5 |
| Pricing | 1mg*5, $1390.00 |